National Oxygen Board of Directors
Get the latest insights into the leadership at National Oxygen. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Rajesh Kumar Saraf | Managing Director |
| Mr. Gajanand Saraf | Whole Time Director |
| Mrs. Sarita Saraf | Director |
| Mr. Shanmugavadivel Siva | Independent Director |
| Mrs. Mona Milan Parekh | Independent Director |
| Mr. Amit Kumar Agarwal | Independent Director |
National Oxygen Share price
NOL
119.2
1.20 (1.02%)Last updated on 4 Sep, 2025 | 13:31 IST
BUYSELL
Today's High
121.00
Today's Low
119.20
52 Week Low
94.95
52 Week High
165.00
The current prices are delayed, login to your account for live prices
LoginNational Oxygen FAQs
The board at National Oxygen consists of experienced professionals, including Mr. Rajesh Kumar Saraf , Mr. Gajanand Saraf , and others, overseeing the company’s strategic and corporate governance.
Directors at National Oxygen are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Rajesh Kumar Saraf is the current chairman at National Oxygen.
Executive directors at National Oxygen are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, National Oxygen adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At National Oxygen, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.